Design and analysis of a clinical trial: Its critical point;Diseño y análisis de un ensayo clínico: El aspecto más crítico

Medicina Clinica

Volumn 122, Issue 5, 2004, Pages 184-189

  Cobo, Erik ^a  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

Clinical trials; Intention to treat; Missing data; Per protocol; Sample attrition

Indexed keywords

ANALYTICAL ERROR; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CORRELATION ANALYSIS; HYPOTHESIS; INFORMATION PROCESSING; LONGITUDINAL STUDY; MEDICAL LITERATURE; METHODOLOGY; PRACTICE GUIDELINE; RELIABILITY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

EID: 1642350838     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13057825     Document Type: Conference Paper

References (30)

1. Rubin DB. Estimating causal effect of treatments in randomized and nonrandomized studies. J Educ Psychol 1974;66:688-701.
2. Holland P. Statistics and causal inference [see discussion]. J Am Stat Assoc 1986;81:945-70.
3. Cobo E. Necesidad y limitaciones de la asignación aleatoria. Med Clin (Barc) 2000;111:73-7.
4. Cobo E. Inclusión de variables en modelos multivariantes. Med Clin (Barc) 2002;115:230-7.
5. Meier P. Comment (compliance as an explanatory variable in clinical trials). J Am Stat Assoc 1991;86:19-22.
6. Lachin J. Statiscal considerations in the intention-to-treat principle. Control Clin Trials 2000;21:167-89.
7. Haynes B. Can it work? Does it work? BMJ 1999;319:652-3.
8. Cobos A, Bigorra J. Investigación de resultados en salud: validez externa, validez interna y diseños posibles. Med Clin (Barc) 2002;118(Supl 3):22-5.
9. Vallvé C. Revisión crítica del ensayo clínico pragmático. Med Clin (Barc) 2003;121:384-8.
10. Steiner LB, Rubin DB. Intention-to-treat analysis and the goals of clincial trials. Clin Pharmacol Ther 1995;57:6-15.
11. Gillins D, Kock G. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug InfJ 1991;25:411-24.
12. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analisis of clinical trials by treatment actually received: is it really an option? Stat Med 1991;10:1595-605.
13. Lewis JA. Statistical issues in the regulation of medicines. States Med 1995;14:127-36.
14. Touloumi G, Pocock SJ, Babiker AG, Darbyshire JH. Impact of missing data due to selective dropouts in cohort studies and clinical trials. Epidemiology 2002;13:347-55.
15. Drop-outs from clinical trials [editorial]. Lancet 1987;2:892-3.
16. Chêne G, Morlat P, Leport C, Hafner R, Dequae L, Charreau I, et al. Intention to treat versus on treatment analyses of clinical trial data. Control Clin Trials 1998;19:223-48.
17. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;13:36-9.
18. Cobo E. Elección del grupo control: (1) Distintas hipótesis, distinta metodología. ICB digital [revista electrónica] 2003;12:2-5 [consultado 07/11/2003]. Disponible en: http: //www.icbdigital.org/icbdigital/pdf/articulo/articulo12.pdf
19. ICH E9 Expert Working Group. ICH tripartite guideline: statistical principles for clinical trials. Stat Med 1999;18:1905-42.
20. Andersen B. Statistical errors in medical journals. Selected examples. Proceedings of 14th ISCB meeting; 1993, september 21-24; Cambridge, UK: International Society for Clinical Biostatistics, 1993; p. 53.
21. Steiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials Clin Pharmacol Ther 1995;57:6-15.
22. Little R, Yau L. Intent-to-treat analisis for longitudinal studies with dropouts. Biometrics 1996;52:1324-33.
23. Efron B. Missing data, imputation and the bootstrap. J Am Stat Assoc 1994;89:463-75.
24. Nich C, Carrol K. «Intention-to-treat» meets «missing data»: implications of alternate strategies for analysing clinical trials data. Drug Alcohol Depen 2002;68:121-30.
25. Loeys T, Goetghebeur E. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance. Biometrics 2003;59:100-5.
26. Efron B, Feldman D. Compliance as an explanatory variable in clinical trials [see discussion]. J Am Stat Assoc 1991;86:1-26.
27. White R, Pocock SJ. Statistical reporting of clinical trials with individual changes from allocated treatment. Stat Med 1996;15:249-62.
28. Wright CC, Sim J. Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis. J Clin Epidemiol 2003;56:833-42.
29. Begg CB, Cho MK, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting randomised controlled trials: the CONSORT statement. J Am Med Assoc 1996;276:637-9.
30. Arnau C, Cobo E, Ribera JM, Cardellach F, Selva A, Urrutia A. Efecto de la revisión estadística en la calidad de los manuscritos publicados en MEDICINA CLÍNICA: estudio aleatorizado. Med Clin (Barc) 2003;121:690-4.